MARATTO

article · Animals

High β-Lactam and Quinolone Resistance of Enterobacteriaceae from the Respiratory Tract of Sheep and Goat with Respiratory Disease

202123 citationsOpen accessKafr el-Sheikh University

Abstract

During the last decade's increase of antimicrobial resistance (AMR) in animals, animal-human transmission has become a major threat. Therefore, the present study aimed to evaluate the genetic basis of AMR in Gram-negative bacteria recovered from sheep and goats with respiratory disease. Nasal and ocular swabs were collected from 69 diseased animals, and 76 Gram-negative bacterial isolates were identified from 59 animals. All isolates were checked phenotypically for resistance and genotypically for different resistance mechanisms, including β-lactam, quinolone, and aminoglycoside resistance. Our results demonstrated that 9.2% (95% CI 4.5-17.8%) of the isolates were multidrug-resistant, with high resistance rates to β-lactams and quinolones, and 11.8% (95% CI 6.4-21%) and 6.6% (95% CI 2.8-14.5%) of the isolates were phenotypically positive for AmpC and ESBL, respectively. Genotypically, <i>bla</i><sub>TEM</sub> was the most identified β-lactamase encoding gene in 29% (95% CI 20-40%) of the isolates, followed by <i>bla</i><sub>SHV</sub> (14.5%, 95% CI 8.3-24.1%) and <i>bla</i><sub>CTX-M</sub> (4%, 95% CI 1.4-11%). Furthermore, 7.9% (95% CI 3.7-16.2%) of the isolates harbored plasmid-mediated quinolone resistance gene <i>qnrS</i>. Our study revealed for the first time to our knowledge high β-lactam and quinolone resistance associated with the bacteria recovered from sheep and one goat with respiratory disease. Furthermore, different antimicrobial resistant determinants were identified for the first time from animals in Africa, such as <i>bla</i><sub>LEN-13/55</sub>, <i>bla</i><sub>TEM-176</sub> and <i>bla</i><sub>TEM-198/214</sub>. This study highlights the potential role of sheep and goats in disseminating AMR determinants and/or resistant bacteria to humans. The study regenerates interest for the development of a One Health approach to combat this formidable problem.

Research topics

  • Antibiotic Resistance in Bacteria
  • Enterobacteriaceae and Cronobacter Research
  • Pharmaceutical and Antibiotic Environmental Impacts

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/ani11082258

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.